Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Liver damage caused by drugs].

G Strohmeyer1, C Weik

  • 1Medizinische Universitätsklinik, Heinrich-Heine-Universität Düsseldorf.

Zeitschrift Fur Gastroenterologie
|July 22, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Gastroenterology - accusations and errors in treatment: evaluation of the completed expertise process in internal medicine of the expert committee of North Rhineland for the years 2001 to 2005].

Zeitschrift fur Gastroenterologie·2008
Same author

[Antibiotic-associated diarrhea].

Deutsche medizinische Wochenschrift (1946)·2003
Same author

5-Fluorouracil plus leucovorin is an effective adjuvant chemotherapy in curatively resected stage III colon cancer: long-term follow-up results of the adjCCA-01 trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2003
Same author

Fluorouracil plus leucovorin as effective adjuvant chemotherapy in curatively resected stage III colon cancer: results of the trial adjCCA-01.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
Same author

[The liver and hereditary hemorrhagic telangiectasia].

Zeitschrift fur Gastroenterologie·2000
Same author

The liver in hereditary hemorrhagic telangiectasia (Weber-Rendu-Osler disease).

Scandinavian journal of gastroenterology·2000
Same journal

[Version 7.0 of the S3 Guideline on Ulcerative Colitis sets out clearly defined treatment goals, an open treatment sequence, and a call for improved cross-sectoral care].

Zeitschrift fur Gastroenterologie·2026
Same journal

Zeitschrift fur Gastroenterologie·2026
Same journal

Zeitschrift fur Gastroenterologie·2026
Same journal

[Updated S3 guideline on ulcerative colitis].

Zeitschrift fur Gastroenterologie·2026
Same journal

Zeitschrift fur Gastroenterologie·2026
Same journal

Zeitschrift fur Gastroenterologie·2026
See all related articles

The liver metabolizes drugs, but some can cause liver injury. Understanding drug metabolism and potential toxic effects is crucial for patient safety and managing liver damage.

Area of Science:

  • Hepatology
  • Pharmacology
  • Toxicology

Background:

  • The liver is the primary site for drug metabolism (biotransformation) of endogenous and exogenous substances.
  • Lipid-soluble drugs require hepatic transformation into water-soluble metabolites for elimination.
  • Drug metabolism can produce toxic metabolites, leading to liver cell damage.

Purpose of the Study:

  • To review the liver's role in drug metabolism.
  • To describe the clinical and morphological spectrum of drug-induced liver injury (DILI).
  • To discuss commonly implicated drugs causing severe DILI.

Main Methods:

  • Literature review of drug metabolism and DILI.
  • Analysis of clinical presentations and pathological findings in DILI.

Related Experiment Videos

  • Detailed discussion of specific drug classes known to cause severe liver injury.

    • Main Results:

    • Drug metabolism in the liver can result in toxic metabolites causing liver injury.
    • DILI presents with diverse clinical symptoms (gastrointestinal, jaundice, liver failure) and morphological changes (hepatitis, cholestasis, fibrosis, tumors).
    • Commonly implicated drugs include anabolics, oral contraceptives, antituberculars, NSAIDs, and antibiotics.

    Conclusions:

    • Drug-induced liver injury is a significant clinical concern with varied presentations.
    • Awareness of drugs potentially causing liver damage is essential for diagnosis and management.
    • Further research into mechanisms and prevention of DILI is warranted.